A review written early in 2008 contained an extensive list of diseases for which excessive and/or misplaced iron has been reported to be a causative or associated risk factor.[@R1] The metal is toxic by catalyzing generation of hydroxyl radicals that intensify oxidative stress as well as by serving as a growth-essential nutrient for invading microbial and neoplasmic cells.

In the subsequent twelve months following submission of the manuscript, four additional conditions in which iron is toxic have been described: (a) intensification of aging muscle atrophy,[@R2] (b) increased replication of human immunodeficiency virus (HIV) and hepatitis C virus (HCV),[@R3] (c) enhancement of rosacea,[@R4] and (d) augmentation of pulmonary alveolar proteinosis (PAP).[@R5] In this paper, the previously published tables of iron-related conditions and of the types of iron association are expanded to include these four conditions.

In the report on muscle atrophy, non-heme iron levels in gastrocnemius muscle in male rats increased by 233% between six and thirty months of age.[@R2] Abundance of mRNA transferrin receptor-1 decreased by 80%. In related research in the same laboratory, non-heme iron and RNA oxidation increased significantly with age in quadriceps-derived subsarcolemma mitochondria.[@R6] In a third related study, in rats between 29 and 37 months of age, non-heme iron in gastrocnemius muscle increased by 200% with an accompanying significant increase in oxidized RNA7 These changes were associated with evidence of sarcopenia; that is, decreased muscle mass and grip.

Although iron is not a component of viruses, infected host cells apparently need the metal to synthesize viral particles. During the past several decades, it has become manifest that one of the dangers of excessive iron is its ability to favor animal viral infections.[@R8] The importance of iron in HIV infection has received particular attention.[@R9] The multi-faceted molecular sites of action of iron in synthesis of HIV, as well as of HCV, are now being compiled.[@R3] Of special interest are indications that viruses can manipulate iron homeostasis so as to ensure their replication in host cells.

Rosacea is a common chronic light-sensitive inflammatory skin disease. In this inquiry, peroxide and antioxidant potential of serum as well as of skin cell ferritin were assayed.[@R4] Serum peroxide levels were higher and total anti-oxidant potential was lower in patients than in healthy controls (p \< 0.05). The number of ferritin positive cells was higher (p \< 0.001) in patient samples especially in those with severe disease. Ultraviolet irradiation of skin plus skin cell iron accelerated development of photo-sensitization, photo- aging and skin cancer.[@R10] It will be of interest to directly measure iron deposits in rosacea cells.

In the investigation on PAP, bronchoalveolar lavage samples of 20 patients were compared with those of 20 healthy volunteers.[@R5] Concentrations of iron, transferrin, transferrin receptor, lactoferrin and ferritin were significantly elevated in PAP relative to healthy persons. In contrast, quantities of ascorbate, glutathione and urate were significantly depressed in PAP patients, indicative of antioxidant depletion. The results suggest an iron-catalyzed oxidative stress in the maintenance of PAP.

Similar alterations in pulmonary iron homeostasis have been observed in several other chronic lung diseases.[@R11]

The list of iron-associated diseases, whose compilation began 25 years ago,[@R12] continues to grow ([Tables 1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}). Recognition of the toxicity of iron is stimulating research efforts to develop iron chelator drugs that might be able to remove the metal from specific disease sites.[@R13],[@R14]
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ALS

:   amyotrophic lateral sclerosis

HCV

:   hepatitis C virus

HIV

:   human immunodeficiency virus

PAP

:   pulmonary alveolar proteinosis

PKAN

:   pantothenate kinase-associated neurodegeneration

###### 

Conditions for which excessive/misplaced iron can be a risk factor

  -------------------- ------------------------------------------ --------------------------
  **Aging**            **Infectious**                             **Ophthalmic**
  muscle atrophy       bacterial, fungal & protozoan infections   macular degeneration
  **Cardiovascular**   viral infections: HIV, HCV                 **Orthopedic**
  atherosclerosis                                                 gout
  cardiomyopathy       **Neurologic**                             hemophilic
  hypertension         ALS                                        synovitis
  ischemic stroke      Alzheimer                                  osteoarthritis
  venous leg ulcer     depression                                 osteoporosis
                       Friedreich                                 ataxia
  **Dermal**           Huntington                                 **Otologic**
  porphyria            multiple sclerosis                         aminoglycoside
  cutanea tarda        Parkinson                                  toxicity
  rosacea              PKAN                                       
                       prion disease                              **Pediatric & Neonatal**
  **Endocrine**                                                   Down syndrome
  diabetes             **Obstetric**                              epilepsy
  endometriosis        neonatal                                   sudden infant death
  growth deficiency    hemochromatosis                            
  hypogonadism         pre-eclampsia                              **Pulmonary**
  hypothyroidism                                                  alveolar proteinosis
                       **Oncologic**                              cystic fibrosis
  **Hepatic**          breast                                     ozone lung injury
  cirrhosis            colorectal                                 pneumoconiosis
  steatohepatitis      esophageal                                 **Renal**
  viral hepatitis      hepatic                                    aminoglycoside &
                       Kaposi sarcoma                             vancomycin toxicity
                       leukemia                                   
                       lung                                       
  -------------------- ------------------------------------------ --------------------------

Modifed from Table 3 (Weinberg et al.)[@R1].

###### 

Association of iron with morbidity

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Iron, by itself, has been observed to initiate the disease**cardiomyopathygrowth deficiencyhemophilic synovitishypogonadismlung cancerosteoporosispneumoconiosis**Iron can be a cofactor in promoting the disease**Alzheimeratherosclerosisbacterial infectionsdiabetesendometriosisesophageal adenocarcinomafungal & protozoan infectionsgouthepatomamultiple sclerosisosteoarthritisoto- & renal toxicityozone lung injurypulmonary alveolar proteinosisviral infections**Iron deposits are observed in disease-associated tissue sites**basal ganglia in PKANhepatocytes in cirrhosis, steatohepatitis & viralhepatitismitochondria in Friedreich ataxiapulmonary secretions in cystic fibrosisretina in macular degenerationskin cells in rosaceaskeletal muscle in agingsubstantia nigra in Parkinsonthyroid in hypothyroidism**Body iron loading is associated with above normal incidence of morbidity**ALSbreast cancercolorectal cancerdepressionDown syndromeepilepsyhypertensionischemic strokeleukemiapre-eclampsiaporphryia cutanea tardaprion diseasesudden infant death syndrome**Maternal antibodies can impair fetal iron metabolism**fetal or neonatal death in neonatal hemochromatosis
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Modified from Table 4 (Weinberg et al.)[@R1].
